Orthotown July/August 2013 - (Page 46)

clear aligners // feature by Jonathan L. Nicozisis, DMD, MS Eighteen months ago an adult patient presented to my office for an Invisalign consult. After being told he was an excellent candidate, he chose not to begin treatment. Last month this patient revisited my website, saw the PROPEL Orthodontics logo and clicked on the link to learn about how it can be used to facilitate tooth movement and decrease length of treatment. He returned to my office for a second consult and had his impressions taken that day. The patient stated that had it not been for the possibility of getting the PROPEL treatment and learning about it from my website, he would not have returned for orthodontic care. This affirmed for me the huge potential benefit of PROPEL. The treatment attracts patients who are unwilling to accept a prolonged treatment time. PROPEL has increased my practice’s bottom line by shortening treatment time, allowing me to treat additional patients, finishing challenging or “stuck” cases and attracting patients who would not otherwise accept treatment. Background Micro-Osteoperforation stimulates cytokine activity accelerating alveolar bone remodeling. This new device developed and patented by PROPEL can be used in a simple, in-office procedure to stimulate alveolar bone remodeling. The PROPEL device was developed from research out of the NYU Department of Orthodontics and has been commercially available since fall 2012. In using a patient’s own biology to facilitate tooth movement, PROPEL does so by creating micro-osteoperforations. This treatment stimulates the local inflammatory response, which induces cytokine activity, thereby stimulating faster bone remodeling.1 An increase in bone remodeling allows teeth to be moved to the desirable location at a faster rate. Research shows that this increased inflammatory response returns to normal levels in six to eight weeks, therefore, the patient must be re-treated every six to eight weeks2 until desired tooth movements are achieved. PROPEL is an FDA Class 1, 510kexempt medical device to be disposed of after a single use. 1. Teixeira CC, Khoo E, Tran J, Chartres I, Liu Y, Thant LM, et al. (2010). Cytokine expression and accelerated tooth movement. J Dent Res 89:1135-1141 2. Khoo E, Tran J, Raptis M, Teixeira CC, Alikhani M (2011). Accelerated Orthodontic Treatment 46 JULY / AUGUST 2013 // orthotown.com http://www.orthotown.com

Table of Contents for the Digital Edition of Orthotown July/August 2013

Introducing the Townie Choice Awards
Knowledge: Change Management’s Best Friend
Efficiency of Advanced Digital Technology for Orthodontic Treatment
The Challenges of Providing Low-income Children with Access to Orthodontic Care
Accelerated Tooth Movement Technology
Playing the Charity Card
One Full-time Employee per $200,000 Collections?
Pros and Cons of .022 Versus .018 Slot Braces
Orthotown.com Highlights
Wired for Success: What Makes a Great Treatment Coordinator?
You Should Know: Cloud9Ortho
You Should Know: Embrace Smiles
You Should Know: Forestadent (an update)
New Products
Ad Index

Orthotown July/August 2013